Clinical Trial Update: Evaluate Tolerability of a Multi-envelope, Prime-boost HIV Vaccine in Healthy Adults [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluated tolerability of a multi-envelope, prime-boost HIV vaccine in healthy adults. The trial was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Multi-envelope, prime-boost HIV vaccine (HIV vaccine (prime-boost))

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: HIV Infections | Phase 1 | Status: TERMINATED